Ado-trastuzumab emtansine and Dopamine Injection, Concentrate
Determining the interaction of Ado-trastuzumab emtansine and Dopamine Injection, Concentrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-Trastuzumab Emtansine
Generic Name: dopamine
Brand name: Intropin
Synonyms: Dopamine Injection, DOPamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine-Dopram
- Ado-trastuzumab emtansine-Doptelet
- Ado-trastuzumab emtansine-Doral
- Ado-trastuzumab emtansine-Doral Tablets
- Ado-trastuzumab emtansine-Doravirine
- Ado-trastuzumab emtansine-Doravirine, lamivudine, and tenofovir
- Dopamine Injection, Concentrate-Ado-trastuzumab emtansine Intravenous
- Dopamine Injection, Concentrate-Adox Pak 2/100
- Dopamine Injection, Concentrate-Adoxa
- Dopamine Injection, Concentrate-Adoxa CK
- Dopamine Injection, Concentrate-Adoxa Pak
- Dopamine Injection, Concentrate-Adoxa Pak 1/100